Who makes ER Tablet under Fasted Conditions?

ER Tablet under Fasted Conditions is developed by Nexgen Pharma, Inc.

What development phase is ER Tablet under Fasted Conditions in?

ER Tablet under Fasted Conditions is in Phase 1.

Last reviewed 2026-04-19 · How we verify

ER Tablet under Fasted Conditions

Nexgen Pharma, Inc · Phase 1 active Small molecule

At a glance

Generic name	ER Tablet under Fasted Conditions
Also known as	Codeine Phosphate/Guaifenesin 30mg/600mg ER Tablet
Sponsor	Nexgen Pharma, Inc
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

ER Tablet under Fasted Conditions CI brief — competitive landscape report
ER Tablet under Fasted Conditions updates RSS · CI watch RSS
Nexgen Pharma, Inc portfolio CI